Heritage
A house, in its own words
Publicly available information on Patrichs is sparse, and no founding date, founder, or geographic origin has been documented in independent sources reviewed for this profile. The earliest entry in the catalog is Patrichs Noir Classic (1995), followed in quick succession by Noir Freedom (1996), Noir Musk (1996), and Noir Mimetic (1996), with Noir Black and Noir White both arriving in 1997. That concentrated three-year release window suggests the house was either newly established in the mid-1990s or had previously operated under a different name or catalog structure. No perfumer attribution appears in standard fragrance databases for any of the six scents. Because no peer-reviewed history, industry interview, or retrospective press feature on Patrichs surfaced during research, the brand's heritage must be read primarily through its output: a small, deliberately masculine Noir series produced at a moment when designer flankers and numbered 'sport' or 'extreme' editions were saturating the European and Latin American markets. Further archival work would be needed to trace the company behind the label with confidence. With no published interviews or manifesto available, Patrichs' philosophy has to be inferred from the naming conventions, release cadence, and composition choices visible across the Noir line. The repeated use of 'Noir' as a single-word anchor across every release signals a commitment to a dark, evening-leaning mood palette rather than the bright citrus or aquatic codes that dominated much of the 1990s men's market. The inclusion of Noir Mimetic alongside more conventional titles points to a curiosity about sensory illusion, mimicry, or novelty within the dark-fragrance framework, distinguishing the house from competitors who treated Noir as a visual cue rather than a creative brief. Patrichs appears to have treated its six fragrances as variations on a single thesis rather than a sprawling catalog, which reads as a curatorial approach: the brand chose to deepen one idea instead of widening its brief.





